首页|人乳头瘤病毒E6∕E7 mRNA检测在宫颈癌筛查、分流中的价值分析

人乳头瘤病毒E6∕E7 mRNA检测在宫颈癌筛查、分流中的价值分析

扫码查看
目的 比较人乳头瘤病毒(HPV)E6∕E7 mRNA 与 HPV-DNA 分别及联合液基薄层细胞学检查(thin-prep cytology test,TCT)在宫颈病变筛查中的价值及HPV E6∕E7 mRNA与HPV-DNA在非典型鳞状细胞(ASC-US)分流中的价值。方法 纳入 2022 年 1 月~2023 年 12 月于扬州大学医学院附属盐城妇幼保健院进行宫颈癌筛查的 2079 名受检者,行TCT、HPV-DNA、HPV E6∕E7 mRNA检测,剔除 3 项结果均阴性者,513 例行阴道镜活检。以病理报告为金标准,比较HPV-DNA和HPV E6∕E7 mRNA的宫颈病变检出率。对HPV-DNA和HPV E6∕E7 mRNA单独筛查及分别联合TCT筛查CIN2+(包括CIN2、CIN3 及宫颈癌)的效能进行比较。对HPV-DNA与HPV E6∕E7 mRNA分流ASC-US的效能进行比较。结果 HPV-DNA CIN1 检出率 4。08%高于HPV E6∕E7 mRNA的 2。45%,差异有统计学意义(χ2=8。787,P=0。003),而两种筛查方法CIN2+检出率差异无统计学意义(χ2=0。250,P=0。617)。HPV-DNA和HPV E6∕E7 mRNA筛查CIN2+的灵敏度为85。98%vs。81。09%、特异度为49。57%vs。84。24%,HPV-DNA的筛查灵敏度高于E6∕E7 mRNA、特异度低于E6∕E7 mRNA,两种筛查方法的特异度、阳性预测值及假阳性率差异有统计学意义(χ2=94。732、32。802、94。732,P=0。000)。TCT 联合 HPV-DNA 和 TCT 联合 HPV E6∕E7 mRNA筛查CIN2+的灵敏度为94。51%vs。90。85%、特异度为85。37%vs。90。26%,联合TCT提高了筛查的灵敏度和特异度,但TCT联合HPV-DNA的筛查特异度仍低于TCT联合HPV E6∕E7 mRNA,两种联合筛查方法的特异度和假阳性率差异有统计学意义(χ2=3。871、3。871,P=0。049)。HPV E6∕E7 mRNA在ASC-US中筛查CIN2+的ROC曲线下面积为 0。814,大于HPV-DNA的 0。704,差异有统计学意义(χ2=2。352,P<0。05)。结论 与HPV-DNA相比,HPV E6∕E7 mRNA单独筛查及分别与TCT联合筛查CIN2+均有更高的特异度,对ASC-US的分流管理更具优势。
Value analysis of HPV E6∕E7 mRNA detection in cervical cancer screening and diversion
Objective To compare the value of HPVE6∕E7 mRNA and HPV-DNA,respectively and in combination with TCT,in screening cervical lesions,and the value of E6∕E7 mRNA and HPV-DNA in ASC-US shunting.Methods 2079 women who underwent cervical cancer screening in our hospital from January 2022 to December 2023 were included in the study.TCT,HPV DNA,and HPV E6∕E7 mRNA tests were performed and those with negative results in all 3 categories were excluded.513 cases underwent vaginal biopsy.Using pathological reports as the gold standard,compare the positivity rates of HPV DNA and HPV E6∕E7 mRNA.Comparison of the efficacy of HPV DNA and HPV E6∕E7 mRNA screening alone and in combination with TCT screening for CIN2+(including CIN2,CIN3,and cervical cancer).Compare the efficiency of ASC-US for HPV DNA and HPV E6∕E7 mRNA diversion.Results The CIN1 rate in the HPV-DNA group was 4.08%,which higher than 2.45%in the E6∕E7 mRNA group(χ2=8.787,P=0.003).There was no statistically significant difference in the CIN2+detection rate between the two screening methods(χ2=0.250,P=0.617).The sensitivity and specificity of HPV-DNA and E6∕E7 mRNA in screening for CIN2+were 85.98%vs.81.09%and 49.57%vs.84.24%,respectively.The sensitivity of HPV-DNA screening was higher than that of E6∕E7 mRNA,while the specificity was lower than that of E6∕E7 mRNA.The differences in specificity,positive predictive value,and false positive rate between the two screening methods were statistically significant(χ2=94.732,32.802,94.732,P=0.000).The sensitivity and specificity of TCT combined with HPV-DNA and TCT combined with E6∕E7 mRNA for screening CIN2+were 94.51%vs.90.85%and 85.37%vs.90.26%,respectively.The combination of TCT improved the sensitivity and specificity of screening,but the specificity of TCT combined with HPV-DNA was still lower than that of TCT combined with E6∕E7 mRNA.The difference in specificity and false positive rate between the two combined screening methods was statistically significant(χ2=3.871,3.871,P=0.049).The area under the ROC curve of E6∕E7 mRNA in screening for CIN2+in ASC-US is 0.814,which is greater than that of HPV-DNA by 0.704,and the difference is statistically significant(χ2=2.352,P<0.05).Conclusion Compared with HPV-DNA,E6∕E7 mRNA alone and in combination with TCT screening for CIN2+have higher specificity,and have more advantages in shunt management of ASC-US.

Cervical cancerHuman papillomavirusE6∕E7 mRNAScreeningDiversion

袁丽娟、耿莉、成如兰、张志娟

展开 >

224000 盐城,扬州大学医学院附属盐城妇幼保健院(盐城市妇幼保健院)妇女保健科

宫颈癌 人乳头瘤病毒 E6∕E7 mRNA 筛查 分流

盐城市医学科技发展计划盐城市医学科技发展计划

YK2021049YK2020057

2024

中华保健医学杂志
中国人民解放军总后勤部卫生部保健局

中华保健医学杂志

CSTPCD
影响因子:0.477
ISSN:1674-3245
年,卷(期):2024.26(5)